News | January 12, 2010

Physicians Overly Optimistic about WBRT Outcomes

January 13, 2010 - Whole brain radiotherapy (WBRT) is often recommended for patients with advanced cancer to receive quick access to palliative radiotherapy.

A recent study published in the International Journal of Radiation Oncology Biology Physics found that physicians referring patients with brain metastases for consideration of WBRT are often overly optimistic when estimating the clinical benefit of the treatment and overestimate patient survival.

The primary objective of the study was to determine what are physician’s expectations of treatment outcomes for patients with brain metastases referred for whole brain radiotherapy (WBRT). As a secondary objective, researchers were trying to understand what factors influence the expectations and to determine the accuracy of the physician-estimated patient survival.

Of the nearly 80 referring physicians surveyed, more than 94.9 percent said they believed WBRT would stabilize neurologic symptoms, improve quality of life, and allow for a Decadron (dexamethasone) taper; 87.0 percent said WBRT would improve performance status; 77.9 percent expected it to improve neurologic symptoms; and 40.8 percent thought it would improve survival. While the actual survival patient survival was a median of two and a half months, the referring physicians estimated patient survival rates would reach six months on average. This discrepancy represented a median individual difference of 1.9 months.

This led researchers to conclude referring physicians’ expectations of WBRT outcomes are often overly optimistic, the physicians tend to over estimate patient survival, and more education and research in this field is needed.

Reference: Barnes, EA; Chow, E; Tsao, MN; Bradley, NM; Doyle, M; Li, K; Lam, K; Danjoux, C. Physician Expectations of Treatment Outcomes for Patients With Brain Metastases Referred for Whole Brain Radiotherapy. Int J Radiat Oncol Biol Phys. 2010 Jan 1;76(1):187-192.

Related Content

Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation
150-Year-Old Drug Might Improve Radiation Therapy for Cancer
News | Radiation Therapy | November 02, 2018
November 2, 2018 — A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more